tiprankstipranks
Syros Pharmaceuticals (SYRS)
NASDAQ:SYRS
US Market

Syros Pharmaceuticals (SYRS) Cash flow

Compare
1,049 Followers

Syros Pharmaceuticals Cash Flow

SYRS's free cash flow for Q3 2024 was $-20.69M. For the 2024 fiscal year, SYRS's free cash flow was decreased by $14.33M and operating cash flow was $-20.69M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -109.71M$ -123.06M$ -99.54M$ -57.36M$ -60.25M
Investing Cash Flow
$ 37.34M$ 67.19M$ -52.65M$ 46.66M$ -11.73M
Financing Cash Flow
$ 43.46M$ 131.04M$ 70.51M$ 142.95M$ 65.99M
End Cash Position
$ 141.65M$ 170.55M$ 95.39M$ 177.07M$ 44.82M
Free Cash Flow
$ -109.98M$ -124.31M$ -100.78M$ -60.70M$ -72.89M
Currency in USD

Syros Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis